Company / R&D per Share
InspireMD, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.51
FY2025
5-year range
$0.37 / $0.94
FY2021-FY2025
Trend
+40.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.08 in FY2020 to $30.27 in FY2017.
Based on SEC 10-K filings.
0.51 in FY2025 with a 5-year CAGR of +46.1%.
Declined from $0.94 to $0.51 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -6.2%
- 5-Year CAGR
- +46.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 40.2% year-over-year.
- Peak r&d per share was recorded in FY2017.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.51 | +40.2% |
| FY2024 | $0.37 | -61.0% |
| FY2023 | $0.94 | +50.8% |
| FY2022 | $0.62 | -8.6% |
| FY2021 | $0.68 | +783.8% |
| FY2020 | $0.08 | -96.1% |
| FY2019 | $2.00 | +132.2% |
| FY2018 | $0.86 | -97.2% |
| FY2017 | $30.27 | +161.0% |
| FY2016 | $11.60 | +448.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026